Bates JH |
Mycobacterium avium disease: progress at last. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665029
|
Wallace RJ et al. |
Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665032
|
Frothingham R |
Clarithromycin treatment for Mycobacterium avium-intracellulare complex lung disease. |
1996 |
Am. J. Respir. Crit. Care Med. |
pmid:8665069
|
Treille S et al. |
Kidney graft dysfunction after drug interaction between clarithromycin and cyclosporin. |
1996 |
Nephrol. Dial. Transplant. |
pmid:8672003
|
Araki J et al. |
[A case of Mounier-Kuhn syndrome]. |
1996 |
Nippon Naika Gakkai Zasshi |
pmid:8708483
|
Lowe SH et al. |
Uveitis during treatment of disseminated Mycobacterium avium-intracellulare complex infection with the combination of rifabutin, clarithromycin and ethambutol. |
1996 |
Neth J Med |
pmid:8710040
|
O'Hara K and Yamamoto K |
Reaction of roxithromycin and clarithromycin with macrolide-inactivating enzymes from highly erythromycin-resistant Escherichia coli. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8849224
|
Segreti J et al. |
In vitro activity of macrolides against intracellular Legionella pneumophila. |
1996 |
Diagn. Microbiol. Infect. Dis. |
pmid:8902407
|
Vermot D et al. |
Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8851620
|
Craig AM et al. |
Decision analysis of Helicobacter pylori eradication therapy using omeprazole with either clarithromycin or amoxicillin. |
1996 |
Pharmacoeconomics |
pmid:10160472
|
|
[Management of atypical Mycobacterium infections in AIDS-patients]. |
1996 |
Internist (Berl) |
pmid:9131082
|
Ednie LM et al. |
Comparative activities of clarithromycin, erythromycin, and azithromycin against penicillin-susceptible and penicillin-resistant pneumococci. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8843313
|
Conte JE et al. |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807050
|
Nash KA and Inderlied CB |
Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. |
1996 |
Antimicrob. Agents Chemother. |
pmid:8807078
|
Tsuyuguchi K |
[In vitro anti-MAC activities of new quinolones in focus (1)]. |
1996 |
Kekkaku |
pmid:8999136
|
Sakatani M |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)]. |
1996 |
Kekkaku |
pmid:8999139
|
Tanaka E |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial]. |
1996 |
Kekkaku |
pmid:8999140
|
Bock H and Mares A |
[Good results with Helicobacter pylori eradication for treatment of non-ulcer dyspepsia]. |
1996 |
Leber Magen Darm |
pmid:9005302
|
Tursi A et al. |
Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication. |
1996 |
Panminerva Med |
pmid:9009677
|
Schimkat M et al. |
Rifabutin-associated anterior uveitis in patients infected with human immunodeficiency virus. |
1996 |
Ger J Ophthalmol |
pmid:8854102
|
Chiba N |
Omeprazole and clarithromycin with and without metronidazole for the eradication of Helicobacter pylori. |
1996 |
Am. J. Gastroenterol. |
pmid:8855737
|
Engelhardt E et al. |
[Postoperative infection with Mycobacterium chelonae]. |
1996 |
Hautarzt |
pmid:9036143
|
Kelleher P et al. |
Uveitis associated with rifabutin and macrolide therapy for Mycobacterium avium intracellulare infection in AIDS patients. |
1996 |
Genitourin Med |
pmid:9038637
|
Thompson D and Oster G |
Use of terfenadine and contraindicated drugs. |
1996 |
JAMA |
pmid:8614120
|
Stone GG et al. |
Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. |
1996 |
Helicobacter |
pmid:9432314
|
Sjöström JE and Larsson H |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant. |
1996 |
J. Med. Microbiol. |
pmid:8636959
|
|
Clarithromycin and omeprazole for Helicobacter pylori. |
1996 |
Med Lett Drugs Ther |
pmid:8637481
|
Pozniak A and Nelson MR |
Against the proposition: all patients with advanced HIV disease should be offered rifabutin prophylaxis. |
1996 |
Genitourin Med |
pmid:8976832
|
Labenz J et al. |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?]. |
1996 |
Dtsch. Med. Wochenschr. |
pmid:8565802
|
Goh KL et al. |
Helicobacter pylori eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. |
1996 |
Eur J Gastroenterol Hepatol |
pmid:8804868
|
Berger C et al. |
Treatment of nontuberculous mycobacterial lymphadenitis with clarithromycin plus rifabutin. |
1996 |
J. Pediatr. |
pmid:8774511
|
Sito E et al. |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777303
|
Gabryelewicz A |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777307
|
Deltenre M et al. |
Strategies for Helicobacter pylori eradication in 1995: a review of international and Belgian experience. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777308
|
Roesch W |
Cost-effectiveness of H. pylori eradication. |
1996 |
J. Physiol. Pharmacol. |
pmid:8777309
|
Flamm RK et al. |
Kill kinetics of antimicrobial agents against Helicobacter pylori. |
1996 |
J. Antimicrob. Chemother. |
pmid:8937967
|
Bermudez LE et al. |
Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model. |
1996 |
J. Infect. Dis. |
pmid:8940212
|
Nagashima R et al. |
Regression of duodenal mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori. |
1996 |
Gastroenterology |
pmid:8942749
|
Ferguson PJ and Saulsbury FT |
Successful treatment of chronic Mycobacterium abscessus otitis media with clarithromycin. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8866816
|
Giacometti A et al. |
In-vitro activity of macrolides alone and in combination with artemisin, atovaquone, dapsone, minocycline or pyrimethamine against Cryptosporidium parvum. |
1996 |
J. Antimicrob. Chemother. |
pmid:8889715
|
Tracy TS and Johns M |
Comment: delirium probably induced by clarithromycin in a patient receiving fluoxetine. |
1996 |
Ann Pharmacother |
pmid:8893135
|
Ghebremichael S et al. |
Antimycobacterial synergism of clarithromycin and rifabutin. |
1996 |
Scand. J. Infect. Dis. |
pmid:8893404
|
Yousfi MM et al. |
Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8871452
|
McLinn S and Williams D |
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media. |
1996 |
Pediatr. Infect. Dis. J. |
pmid:8878239
|
Gross U and Pohl F |
Influence of antimicrobial agents on replication and stage conversion of Toxoplasma gondii. |
1996 |
Curr. Top. Microbiol. Immunol. |
pmid:8791704
|
Peterson WL et al. |
Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791947
|
Delchier JC et al. |
Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791948
|
Jaup BH and Norrby A |
Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of H. pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791950
|
Weldon MJ et al. |
A seven-day Helicobacter pylori treatment regimen using clarithromycin, omeprazole and tripotassium dicitrato bismuthate. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791951
|
Tursi A et al. |
Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8791952
|
Pierce M et al. |
A randomized trial of clarithromycin as prophylaxis against disseminated Mycobacterium avium complex infection in patients with advanced acquired immunodeficiency syndrome. |
1996 |
N. Engl. J. Med. |
pmid:8663871
|
Rastogi N et al. |
In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. |
1996 |
Curr. Microbiol. |
pmid:8672093
|
|
Clarithromycin and MAC. |
1996 |
AIDS Patient Care STDS |
pmid:11361673
|
Harris AW et al. |
Lansoprazole, clarithromycin and metronidazole for seven days in Helicobacter pylori infection. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971302
|
Moshkowitz M et al. |
One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971304
|
Laine L et al. |
Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori. |
1996 |
Aliment. Pharmacol. Ther. |
pmid:8971306
|
Naoki K et al. |
[Two cases of pulmonary disease caused by Mycobacterium chelonae subsp. abscessus]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8976085
|
Iwata M et al. |
[Bronchiolitis obliterans preceding rheumatoid arthritis: effect of clarithromycin]. |
1996 |
Nihon Kyobu Shikkan Gakkai Zasshi |
pmid:8976086
|
Amsden GW |
Erythromycin, clarithromycin, and azithromycin: are the differences real? |
1996 Jan-Feb |
Clin Ther |
pmid:8851453
|
Sander P et al. |
Ribosomal drug resistance in mycobacteria. |
1996 Jan-Feb |
Res. Microbiol. |
pmid:8761724
|
Papp J et al. |
Efficacy of nizatidine, clarithromycin and bismuth subcitrate therapy for Helicobacter pylori eradication in duodenal ulcer patients--a preliminary report. |
1996 Jul-Aug |
Br J Clin Pract |
pmid:8794601
|
Tursi A et al. |
One-week low-dose triple therapy vs. two-week medium-dose double therapy for H.pylori infection. |
1996 Jul-Aug |
Hepatogastroenterology |
pmid:8884304
|
Sketris IS et al. |
Possible role of the intestinal P-450 enzyme system in a cyclosporine-clarithromycin interaction. |
1996 Mar-Apr |
Pharmacotherapy |
pmid:8820476
|
Akamatsu H et al. |
Enhanced effect of clarithromycin on neutrophil function in vitro. |
1996 Mar-Apr |
J. Int. Med. Res. |
pmid:8737228
|
Nightingale SL |
From the Food and Drug Administration. |
1996 May 22-29 |
JAMA |
pmid:8622234
|
Prescott LM |
Clarithromycin for MAC prevention offers additional benefits. |
1996 May-Jun |
Posit Aware |
pmid:11363431
|
Mertl SL |
The role of clarithromycin in the prophylaxis of disseminated Mycobacterium avium-intracellulare infection in patients with AIDS. |
1996 May-Jun |
Pharmacotherapy |
pmid:8726597
|
Ono T et al. |
In vitro and in vivo antibacterial activities of clarithromycin. |
1996 May-Jun |
Chemotherapy |
pmid:8983882
|
Peeling RW and Brunham RC |
Chlamydiae as pathogens: new species and new issues. |
1996 Oct-Dec |
Emerging Infect. Dis. |
pmid:8969247
|
Phull PS et al. |
Lansoprazole plus clarithromycin: evaluation of a new dual therapy for Helicobacter pylori eradication. |
1996 Oct-Nov |
Br J Clin Pract |
pmid:9015906
|
Saluja A et al. |
A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. |
1997 |
Dermatol Surg |
pmid:9236871
|
Gisbert JP et al. |
[One-week treatment with omeprazole, clarithromycin and amoxicillin: high efficacy in the eradication of Helicobacter pylori and cicatrization of duodenal ulcer]. |
1997 |
Med Clin (Barc) |
pmid:9190436
|
Damianos AJ and McGarrity TJ |
Treatment strategies for Helicobacter pylori infection. |
1997 |
Am Fam Physician |
pmid:9191460
|
Rodrigues AD et al. |
Oxidative metabolism of clarithromycin in the presence of human liver microsomes. Major role for the cytochrome P4503A (CYP3A) subfamily. |
1997 |
Drug Metab. Dispos. |
pmid:9152603
|
Garrison MW et al. |
Influence of pH on the antimicrobial activity of clarithromycin and 14-hydroxyclarithromycin against Haemophilus influenzae using an in vitro pharmacodynamic model. |
1997 |
Diagn. Microbiol. Infect. Dis. |
pmid:9154410
|
Rodrigo Sáez L et al. |
[The efficacy of using a short course of 6-day duration (OCA-6) in the treatment to eradicate Helicobacter pylori infection. Omeprazole, clarithromycin, amoxicillin]. |
1997 |
Rev Esp Enferm Dig |
pmid:9115827
|
Fischbach W et al. |
Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. |
1997 |
Lancet |
pmid:8988128
|
Wright DH |
Regression of mucosa-associated lymphoid-tissue lymphoma after eradication of Helicobacter pylori. |
1997 |
Lancet |
pmid:9314895
|
Picardeau M et al. |
Use of different molecular typing techniques for bacteriological follow-up in a clinical trial with AIDS patients with Mycobacterium avium bacteremia. |
1997 |
J. Clin. Microbiol. |
pmid:9316897
|
Chey WD et al. |
Bismuth subsalicylate instead of metronidazole with lansoprazole and clarithromycin for Helicobacter pylori infection: a randomized trial. |
1997 |
Am. J. Gastroenterol. |
pmid:9317068
|
de'Clari F |
Ciprofloxacin was the culprit--not itraconazole. |
1997 |
Clin. Infect. Dis. |
pmid:8994764
|
Raasveld MH et al. |
Cat-scratch disease mimicking pancreatic malignancy: case report. |
1997 |
Clin. Infect. Dis. |
pmid:8994767
|
Taylor JL et al. |
Pharmacoeconomic comparison of treatments for the eradication of Helicobacter pylori. |
1997 |
Arch. Intern. Med. |
pmid:8996045
|
Dautzenberg B |
Rationale for the prevention of disseminated Mycobacterium avium-intracellulare complex disease. |
1997 |
Drugs |
pmid:9358194
|
Cohn DL |
Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. |
1997 |
Drugs |
pmid:9358195
|
Mikasa K et al. |
[Effect of clarithromycin on prolonging the life expectancy of patients with primary lung cancer]. |
1997 |
Jpn J Antibiot |
pmid:9597439
|
Takeda H et al. |
[Macrolide antibiotic actions on bacteria and cultured airway cells]. |
1997 |
Jpn J Antibiot |
pmid:9597448
|
Mita Y et al. |
[Vitamin D3 induction of differentiation of HL-60 cells to monocyte- like cells and their aggregation--a dynamic culture method and clarithromycin]. |
1997 |
Jpn J Antibiot |
pmid:9597462
|
Bazzoli F and Pozzato P |
Therapy of H. pylori infection. |
1997 |
J. Physiol. Pharmacol. |
pmid:9440054
|
Dixon JS et al. |
Ranitidine bismuth citrate plus clarithromycin for the eradication of H. pylori. |
1997 |
J. Physiol. Pharmacol. |
pmid:9440055
|
Yatsunami J et al. |
Clarithromycin is a potent inhibitor of tumor-induced angiogenesis. |
1997 |
Res Exp Med (Berl) |
pmid:9440137
|
Konishi T and Nakao M |
Antibiotic treatment in mice infected with Japanese Borrelia garinii: efficacy of ceftriaxone for eradicating the infection induced by Ixodes persulcatus tick bites. |
1997 |
Microbiol. Immunol. |
pmid:9087959
|
Pérez Mota A et al. |
Helicobacter pylori, efficacy of the new triple therapy in six and twelve-day schedules. |
1997 |
Rev Esp Enferm Dig |
pmid:9494375
|
Payen MC et al. |
[Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection]. |
1997 |
Rev Mal Respir |
pmid:9496599
|
Uemura N et al. |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. |
1997 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:9264278
|
Mor N and Esfandiari A |
Synergistic activities of clarithromycin and pyrazinamide against Mycobacterium tuberculosis in human macrophages. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9303411
|
Savarino V et al. |
A new 1-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus two antibiotics. |
1997 |
Aliment. Pharmacol. Ther. |
pmid:9305478
|
Polis MA et al. |
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infection. |
1997 |
Antimicrob. Agents Chemother. |
pmid:9257746
|
Shibata K et al. |
Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori. |
1997 |
Jpn J Antibiot |
pmid:9258741
|
Sato K et al. |
[Anti-Mycobacterium avium complex activities of KRM-1648, clarithromycin and levofloxacin in 7HSF medium at peak or average blood concentrations after their oral administration of clinical dosages]. |
1997 |
Kekkaku |
pmid:9259129
|